» Articles » PMID: 29915406

Characterization of Mucoid and Serous Middle Ear Effusions from Patients with Chronic Otitis Media: Implication of Different Biological Mechanisms?

Overview
Journal Pediatr Res
Specialties Biology
Pediatrics
Date 2018 Jun 20
PMID 29915406
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic otitis media with effusion (COME) is characterized by persistent middle ear effusions that are in most cases highly viscous, but some patients present with serous fluid. This study aimed at comprehensively characterizing the macromolecular composition of mucoid vs. serous middle ear effusions (MEEs).

Methods: MEEs from patients with COME were analyzed for proteins by mass spectrometry (MS) and western blot techniques, total DNA quantity, bacterial DNA (16S sequencing), and cytokine content. Proteomics datasets were studied in Ingenuity Pathway Analysis (IPA).

Results: Mucoid samples showed a global tendency of increased pro-inflammatory mediators. Interleukin-1β (IL-1β) and IL-10 were significantly more abundant in serous samples (p < 0.01). Mucoid samples had higher DNA quantity (p = 0.04), more likely to be positive in MUC5B protein (p = 0.008) and higher peptide counts (12,786 vs. 2225), as well as an overall larger number of identified proteins (331 vs. 177), compared to serous. IPA found the mucoid sample dataset to be related to immune cell function and epithelial remodeling, whereas the serous sample dataset showed acute responses and blood-related proteins. Interestingly, serous samples showed more bacterial DNA than mucoid ones, with less bacterial genera variability.

Conclusion: This study demonstrates divergent immune responses in children with COME by effusion quality.

Citing Articles

[Current hypotheses on the development of chronic otitis media with effusion in childhood].

Runge A, Straif S, Santer M, Hofauer B, Riechelmann H HNO. 2025; .

PMID: 40019513 DOI: 10.1007/s00106-025-01571-x.


DNA Methylation Patterns Associated with Tinnitus in Young Adults-A Pilot Study.

Bhatt I, Raygoza Garay J, Torkamani A, Dias R J Assoc Res Otolaryngol. 2024; 25(5):507-523.

PMID: 39147981 PMC: 11528087. DOI: 10.1007/s10162-024-00961-2.


In Vivo Optical Characterization of Middle Ear Effusions and Biofilms During Otitis Media.

Won J, Monroy G, Khampang P, Barkalifa R, Hong W, Chaney E J Assoc Res Otolaryngol. 2023; 24(3):325-337.

PMID: 37253962 PMC: 10335988. DOI: 10.1007/s10162-023-00901-6.


Wideband Tympanometry and Absorbance for Diagnosing Middle Ear Fluids in Otitis Media with Effusion.

Senturk M, Ardic F, Tumkaya F, Kara C J Int Adv Otol. 2023; 19(2):140-148.

PMID: 36975086 PMC: 10152103. DOI: 10.5152/iao.2023.22697.


Trans-cortical vessels in the mouse temporal bulla bone are a means to recruit myeloid cells in chronic otitis media and limit peripheral leukogram changes.

Azar A, Bhutta M, Del-Pozo J, Milne E, Cheeseman M Front Genet. 2022; 13:985214.

PMID: 36246635 PMC: 9555619. DOI: 10.3389/fgene.2022.985214.


References
1.
Ubell M, Kerschner J, Wackym P, Burrows A . MUC2 expression in human middle ear epithelium of patients with otitis media. Arch Otolaryngol Head Neck Surg. 2008; 134(1):39-44. PMC: 2912163. DOI: 10.1001/archoto.2007.10. View

2.
Yabe R, Higo R, Sugita K, Iwamori M . Gel chromatographic characterization of proteins in mucous and serous middle ear effusions of patients with otitis media in comparison to serum proteins. Eur Arch Otorhinolaryngol. 2007; 265(3):293-8. DOI: 10.1007/s00405-007-0449-z. View

3.
Rose M, Voynow J . Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev. 2005; 86(1):245-78. DOI: 10.1152/physrev.00010.2005. View

4.
Elsheikh M, Mahfouz M . Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion. Laryngoscope. 2006; 116(3):365-9. DOI: 10.1097/01.MLG.0000195290.71090.A1. View

5.
Grubb M, Spaugh D . Treatment failure, recurrence, and antibiotic prescription rates for different acute otitis media treatment methods. Clin Pediatr (Phila). 2010; 49(10):970-5. DOI: 10.1177/0009922810370363. View